Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia Adriana Seber; Claudio Galvão de CastroJunior; Lucila N. Kerbauy; Alexandre V. Hirayama; Carmem Bonfim; Juliana Folloni Fernandes; Mair Souza; Rony Schafell; Samir Nabhan; Sandra Regina Loggetto; Belinda Pinto Simões; Vanderson Rocha; Marcos de Lima; Renato L. Guerino-Cunha; Henrique Bittencourt;

Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation Maura R.V. Ikoma-Colturato; Miriam P. Beltrame; Felipe M. Furtado; Glicinia Pimenta; Elaine Sobral da Costa; Ana Paula Azambuja; Mariester Malvezzi; Mihoko Yamamoto;

A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia Maryam Aghasipour; Fatemeh Asadian; Seyed Alireza Dastgheib; Kamran Alijanpour; Ali Masoudi; Maedeh Barahman; Mohammad Golshan-Tafti; Reza Bahrami; Amirmasoud Shiri; Hossein Aarafi; Kazem Aghili; Hossein Neamatzadeh;